Is the Regis Healthcare Ltd share price in the buy zone after today's result?

The Regis Healthcare Ltd (ASX:REG) share price has edged higher in morning trade following an improved half-year result. But is it a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price is finishing the week strongly following the release of its half-year results. In early trade the aged care operator's shares have climbed 2.5% to $4.75.

Here's what you need to know:

  • Revenue from ordinary activities increased 20% to $284.7 million on the prior corresponding period.
  • EBITDA of $61.8 million, 20% higher than normalised EBITDA in the first-half of FY 2016.
  • Half-year net profit after tax increased 9% to $30.9 million.
  • Revenue per occupied bed day of $281 compared with $271 in the prior corresponding period.
  • Diluted earnings per share of 10.3 cents.
  • Interim dividend of 10.3 cents per share, payable 20 March 2017.

Considering the difficulties that the aged care sector has faced in the last 12 months, I feel this was a solid result and justifies the rise in its share price in the last few months.

Management advised that the strong EBITDA growth was the result of an increased contribution from its refurbishment program, growth initiatives, and the acquisition of facilities acquired from Masonic Care Queensland.

This offset an impact on earnings from the closure of Regis Park in Western Australia for redevelopment and costs related to two news development in North Fremantle and East Malvern.

During the half the company's average occupancy percentage increased slightly to 95.3%, with revenue per occupied bed day also increasing slightly to $281.

Refundable accommodation deposits (RADs) rose to 2,443, with the dollar value of RADs held rising $46.8 million to a total of $850.9 million.

For the full-year management has reaffirmed its previous guidance of net RAD inflows of around $100 million.

Should you invest?

Like Estia Health Ltd (ASX: EHE) yesterday, I think this was a much improved performance from Regis.

But despite this I would still pick rival Japara Healthcare Ltd (ASX: JHC) over its peers. I believe its experienced management team and long runway for growth have set it up for success in the long-term.

However, it is worth remembering that the Federal Government has announced changes to its residential aged care funding. These changes are in place now, but are not expected to impact the industry significantly until 2018 and onwards. So investors might want to approach the industry with a touch of caution.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »